Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu (Q47849023)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu |
scientific article |
Statements
1 reference
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu (English)
1 reference
Eugene S Chung
1 reference
Milton Packer
1 reference
Kim Hung Lo
1 reference
Adedigbo A Fasanmade
1 reference
James T Willerson
1 reference
Anti-TNF Therapy Against Congestive Heart Failure Investigators
1 reference
9 June 2003
1 reference
1 reference
107
1 reference
3133-3140
1 reference
25
1 reference
Identifiers
1 reference